Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide analysis of gene expression in Calu-1 cells treated with cholesterol synthesis inhibitors

ABSTRACT: The hypothesis tested in this experiment was that a statin caused a larger shift in genes associated with pluripotency when compared with a Δ-24 oxidoreductase. It was theorized that the effect of the statin would be greater since the enzyme inhibition takes place proximal to the pathway branch involved in signal isoprenylation, whereas the oxidoreductase inhibits distal to this branch.

ORGANISM(S): Homo sapiens

PROVIDER: GSE47458 | GEO | 2015/10/14

SECONDARY ACCESSION(S): PRJNA205697

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Genome-wide analysis of gene expression in MDA-MB-231 cells treated with cholesterol synthesis inhibitors

Project description:The hypothesis tested in this experiment was that a statin caused a larger shift in genes associated with pluripotency when compared with a Δ-24 oxidoreductase. It was theorized that the effect of the statin would be greater since the enzyme inhibition takes place proximal to the pathway branch involved in signal isoprenylation, whereas the oxidoreductase inhibits distal to this branch.

2015-10-14 | GSE47461 | GEO

Genome-wide analysis of gene expression in Calu-1 cells and MDA-MB-231 cells treated with cholesterol synthesis inhibitors

Project description:The hypothesis tested in this experiment was that there would be a different response between the cell types to the bisphosphonate, the SREBP inhibitor fatostatin and an oxidoreductase inhibitor.

2015-10-14 | GSE70027 | GEO

miRNA Microarray of cholesterol loaded and cholesterol depleted THP-1 macrophages

Project description:THP-1 macrophages were treated with acLDL to load with cholesterol THP-1 macrophages were treated with statin to deplete cholesterol

2020-04-14 | GSE144751 | GEO

Cholesterol in macrophage regulate gene expersion with or without LPS [statin and LPS RNA-seq]

Project description:cholesterol reduction in macrophages by methyl-b-cyclodextran (MCD) or statin alters gene expression. When activated by inflammatory stimilus LPS, macrophages responded in a cholesterol specific fashion.

2024-04-26 | GSE196188 | GEO

Cholesterol in macrophage regulate gene expersion with or without LPS [MCD and LPS RNA-seq]

2024-04-26 | GSE196187 | GEO

Temporal dynamics of histone modification H3K9/14ac, H3K27ac, H3K4me3, H3K27me3, and H3K36me3 after wounding in Arabidopsis thaliana.

Project description:After wounding in plants, a vast and rapid transcriptional reprogramming takes place. Interestingly, this reprogramming includes the reactivation of developmental regulators that in mature tissue normally are epigenetically repressed. We evaluated which histone modifications are associated with this rapid increase of these developmental regulators.

2019-11-28 | E-MTAB-7611 | biostudies-arrayexpress

CPEB4 regulate mRNA involved in adipogenesis and macrophage recruitment in white adipose tissue.

Project description:Study of the potential CPEB4 mRNA targets in 3T3-L1 adipocytes. Here we show how CPEB4 is critical for the adipocye maturation during adipogenesis as well as contibute to the macrophage recruitment that takes place during adipose tissue expansion

2021-12-01 | GSE163733 | GEO

Liver transcriptome of statin-treated patients

Project description:Background: Clinical data identified an association between the use of HMG-CoA reductase inhibitors (statins) and incident diabetes in patients with underlying diabetes risk factors such as obesity, hypertension and dyslipidemia. The molecular mechanisms however are unknown. Methods: An observational cross-sectional study included 910 severely obese patients, mean (SD) body mass index 46.7 (8.7), treated with or without statins (ABOS cohort: a biological atlas of severe obesity). Data and sample collection took place in France between 2006 and 2016. Transcriptomic signatures of statin treatment in human liver obtained from genome-wide transcriptomic profiling of five different statin drugs using microarrays were correlated to clinico-biological phenotypes and also assigned to biological pathways and mechanisms. Results: We determined the hepatic, statin-related gene signature from genome-wide transcriptomic profiling in severely obese patients with varying degrees of glucose tolerance and cardio-metabolic comorbidities. Patients on statin treatment showed higher diabetes prevalence (OR=2.67; 95%CI, 1.60-4.45; P= 0.0002) and impairment of glucose homeostasis. This phenotype was associated with molecular signatures of increased hepatic de novo lipogenesis (DNL) via activation of sterol regulatory element-binding protein-1 (SREBP1) and concomitant upregulation of the expression of key genes in both fatty acid and triglyceride metabolism. Conclusions: DNL gene activation profile in response to statins was associated with insulin resistance and the diabetic status of the patients. Identified molecular signatures thus suggest that statin treatment increases the risk for diabetes in humans at least in part via induction of DNL.

2019-05-15 | GSE130991 | GEO

Trans-differentiation takes place without reprogramming of developmental-specific DNA methylation, a key determinant of stable cell identity

Project description:Trans-differentiation takes place without reprogramming of developmental-specific DNA methylation, a key determinant of stable cell identity

| PRJNA1060271 | ENA

Transcriptional programs that regulate brain cortical development

Project description:Dynamic changes of histone epigenetic modifications and chromatin structure represent an universal mechanism by which cells adapt their transcriptional response to rapidly changing environmental conditions. During neuronal development, extensive chromatin remodelling takes place allowing the transition of pluripotent cells into differentiated neurons. Here we investigate the transcriptional programs that are differentially regulated during cortical development in vivo.

2015-06-27 | GSE70298 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data